David Bertwistle
About David Bertwistle
David Bertwistle is the Associate Director of Worldwide Health Economics and Outcomes Research at Bristol-Myers Squibb, based in London. He has extensive experience in health economics, having worked at Eli Lilly, IMS Health, i3 Research, Howard Hughes Medical Institute, and the Institute of Cancer Research.
Title
David Bertwistle is the Associate Director, Worldwide Health Economics and Outcomes Research at Bristol-Myers Squibb in London, Greater London, United Kingdom.
Company
David Bertwistle is currently employed at Bristol-Myers Squibb, where he works in the capacity of Associate Director for Worldwide Health Economics and Outcomes Research based in London, Greater London, United Kingdom.
Previous Employment at Eli Lilly and Company
David Bertwistle previously worked at Eli Lilly and Company as a Senior Research Scientist in Global Patient Outcomes and Real World Evidence from 2014 to 2017 in London, Greater London, United Kingdom.
Previous Employment at IMS Health
Before joining Eli Lilly, David served as a Senior Consultant for Health Economics and Outcomes Research at IMS Health from 2008 to 2014 in Alexandria, Virginia, United States.
Previous Employment at I3 Research
David Bertwistle worked as a Manager at I3 Research from 2006 to 2008 in Maidenhead, Royal Borough of Windsor and Maidenhead, United Kingdom.
Previous Employment at Howard Hughes Medical Institute
Between 2000 and 2006, David served as a Research Scientist at the Howard Hughes Medical Institute in Memphis, Tennessee, United States.
Previous Employment at Institute of Cancer Research
From 1996 to 2000, David Bertwistle worked as a Research Scientist at the Institute of Cancer Research in London, Greater London, United Kingdom.
Education and Expertise
David Bertwistle holds a Master of Science from City, University of London, which he achieved in 2008-2009. He also earned a Bachelor of Science and a Doctor of Philosophy from King's College London.
Published Research
David has published multiple peer-reviewed articles in the field of health economics and outcomes research. His work is widely recognized and has been presented at international conferences such as ISPOR (International Society for Pharmacoeconomics and Outcomes Research).
Health Economic Models Development
David contributed to the development of health economic models used to support reimbursement decisions for new therapies. His collaborations with global teams have been instrumental in influencing healthcare policy decisions.
Mentorship and Career Development
Actively involved in mentoring junior researchers, David has guided numerous individuals in their career development within the field of health economics and outcomes research.
Integrating Health Economics into Clinical Development
David has participated in cross-functional teams to integrate health economics insights into clinical development programs, ensuring that economic factors are considered in the development of new therapies.